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Background: The impacts of metabolic syndrome (MetS) and chronic kidney disease (CKD) on short- and long-term outcomes in patients after 
acute myocardial infarction (AMI) have not been described. This study is aimed to evaluate the prognostic importance of MetS and CKD in patients 
after AMI.
Methods: From 2000 to 2006, we retrospectively investigated the 30-day mortality and long-term MACE in 4 groups of total 1,026 consecutive 
AMI patients: 152 CKD patients with MetS, 165 CKD patients without MetS, 301 non-CKD patients with MetS, 408 non-CKD patients without MetS. 
MetS was defined as at least three of the following 5 component conditions (modified NCEP-ATP III criteria); glucose intolerance, obesity (body mass 
index≥25kg/m2), hypertriglyceridemia, low HDL cholesterol and hypertension. CKD was defined estimated glomerular filtration rate < 60ml/min.
Results: The 30-day mortality of CKD patients with MetS was significantly higher than that of the patients (Figure 1). In multivariate analysis, CKD 
was a strong independent predictor of 30-day mortality (relative ratio = 3.01, p<0.001). Long-term MACE of MetS patients with and without CKD was 
significantly higher than that of non-MetS pateints (Figure 2). In multivariate analysis, MetS was a strong independent predictor of long-term MACE 
(hazard ratio = 1.18, p<0.01).
Conclusions: CKD as a predictor of short-term mortality and MeS as a predictor of long-term cardiac events would be important in patients after 
AMI.
